Skip to main content
F
Formulate
Jobs
Companies
Drugs
Advisor
NEW
Insider Intel
Salary
Toggle theme
Toggle theme
Menu
argenx Jobs | Formulate
Jobs
argenx
argenx Jobs
Belgium - Zwijnaarde
Biotechnology
argenx is a life sciences company focused on Antibody therapies.
50
open positions at argenx
View Full Profile
Scientist Preclinical Product Development
argenx
Posted Yesterday
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Research & Development
Immunology
MID
H-1B · 1 FY23
Head of Procurement
argenx
Posted Yesterday
Gent, Belgium; Boston, MA, USA
$204K - $333K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Supply Chain
Immunology
Executive
H-1B · 1 FY23
Finance Business Partner R&D
argenx
Posted 3d ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Research & Development
Immunology
MID
H-1B · 1 FY23
Key Account Manager (m/w/d) – Rare Disease (Nord/West) | Gebiet eigenständig führen
argenx
Posted 6d ago
Germany - Field
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Rare Diseases
MANAGER
H-1B · 1 FY23
Internal Event Leader - Ghent Campus
argenx
Posted 1w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Medical Science Liaison - Houston and Austin
argenx
Posted 1w ago
United States - Field
$80K - $172K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Medical Affairs
Immunology
MID
H-1B · 1 FY23
Supply Chain Manager
argenx
Posted 1w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Supply Chain
Immunology
MANAGER
H-1B · 1 FY23
Head of Medical Safety Assessment
argenx
Posted 1w ago
Remote
$292K - $402K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Executive
H-1B · 1 FY23
Associate Director, US Patient Advocacy
argenx
Posted 1w ago
Remote
$164K - $226K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Executive
H-1B · 1 FY23
Principal Scientist Bioanalytics
argenx
Posted 1w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Research & Development
Immunology
Senior
H-1B · 1 FY23
Regional Account Director, Southeast
argenx
Posted 2w ago
United States - Field
$200K - $275K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Executive
H-1B · 1 FY23
Global Medical Safety Lead
argenx
Posted 2w ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Senior
H-1B · 1 FY23
Associate Director, Patient Advocacy - Canada
argenx
Posted 2w ago
Toronto
$159K - $209K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Executive
H-1B · 1 FY23
Head of Product Quality Manufacturing and Testing
argenx
Posted 3w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Manufacturing
Immunology
Executive
H-1B · 1 FY23
Director, US Compliance
argenx
Posted 3w ago
Boston, MA, USA
$204K - $281K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Legal
Immunology
Executive
H-1B · 1 FY23
Early Development Global Regulatory Lead
argenx
Posted 3w ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Regulatory Affairs
Immunology
Senior
H-1B · 1 FY23
Vice President, HCP Experience Lead
argenx
Posted 3w ago
Remote
$356K - $490K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Executive
H-1B · 1 FY23
Vice President, Insights, Analytics & Digital US Commercial Lead
argenx
Posted 3w ago
Boston, MA, USA
$280K - $385K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
Executive
H-1B · 1 FY23
Sr. Director, Patient Marketing Dual Asset Strategy
argenx
Posted 3w ago
Boston, MA, USA
$236K - $325K
Full-time
Related drug:
VYVGART
Related drug:
VYVGART HYTRULO
Related drug:
HYDASE
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
Executive
H-1B · 1 FY23
Senior Director (Head), US Government Price Reporting
argenx
Posted 1mo ago
Remote
$240K - $330K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Executive
H-1B · 1 FY23
1
2
3
Next
Company Overview
Active Jobs
50
Pipeline Programs
86
Drug Products
2
Clinical Trials
83
View Full Company Profile
Therapeutic Areas
Neurology
Immunology
Oncology
Links
Company Website
Careers Page
Hematology
Rare Diseases